Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $223.05M.
ENTERPRISE VALUE (EV)
$223.05M
InflaRx N.V.
Market Cap
$241.56M
Enterprise Value (EV)
$223.05M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| InflaRx N.V. (IFRX) | $241.56M | $223.05M |
| Akebia Therapeutics, Inc. (AKBA)vs › | $242.34M | $140.76M |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | $366.79M |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.31M | $155.56M |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | N/A |
| High Tide Inc. (HITI)vs › | $237.69M | $292.15M |
| BioAge Labs Inc. (BIOA)vs › | $237.40M | $166.27M |
| MacroGenics, Inc. (MGNX)vs › | $236.45M | $157.64M |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $246.67M | $237.79M |
| Invivyd, Inc. (IVVD)vs › | $248.06M | $96.37M |
Market Cap
$241.56M
Total Debt
$301673.47
Cash
$18.81M
Enterprise Value
$223.05M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
